about
Dose-Dependent Effects of L-Arginine on PROP Bitterness Intensity and Latency and Characteristics of the Chemical Interaction between PROP and L-ArginineThe extreme hyper-reactivity of selected cysteines drives hierarchical disulfide bond formation in serum albumin.Salivary biomarkers and proteomics: future diagnostic and clinical utilities.Peptide labeling with photoactivatable trifunctional cadaverine derivative and identification of interacting partners by biotin transfer.Thymosin β4 and β10 in Sjögren's syndrome: saliva proteomics and minor salivary glands expression.Cervical mucus proteome in endometriosis.Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma.The triple-I (interactive, intersectorial, interdisciplinary) approach to validate "omics" investigations on body fluids and tissues in perinatal medicine.Proteomics applied to pediatric medicine: opportunities and challenges.Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains.Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.The intriguing heterogeneity of human salivary proline-rich proteins: Short title: Salivary proline-rich protein species.Marked Differences in the Submandibular Salivary Proteome between Sardinian Alcohol-Preferring and Sardinian Alcohol-Non Preferring Rats Revealed by an Integrated Top-Down-Bottom-Up Proteomic Platform.Salivary Cystatins: Exploring New Post-Translational Modifications and Polymorphisms by Top-Down High-Resolution Mass Spectrometry.Proteomics in pediatric cystic craniopharyngioma.Proteomic characterization of the qualitative and quantitative differences in cervical mucus composition during the menstrual cycle.Top-down HPLC-ESI-MS proteomic analysis of saliva of edentulous subjects evidenced high levels of cystatin A, cystatin B and SPRR3.Semen proteomics reveals the impact of Enterococcus Faecalis on male fertility.Cryptides: latent peptides everywhere.Testosterone and FSH modulate Sertoli cell extracellular secretion: Proteomic analysis.Characterization of the Protein Components of Matrix Stones Sheds Light on S100-A8 and S100-A9 Relevance in the Inflammatory Pathogenesis of These Rare Renal Calculi.Top-down proteomic characterization of DAOY medulloblastoma tumor cell line.Protein nitration profile of CD3 lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detectionThymosin fraction 5 re-evaluated after 35 years by high-resolution mass spectrometryThe extreme hyper-reactivity of Cys94 in lysozyme avoids its amorphous aggregationMass spectrometry characterization of DOTA-Nimotuzumab conjugate as precursor of an innovative β − tracer suitable in radio-guided surgeryInvestigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior.Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's diseaseThe activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of actionExtensive Characterization of the Human Salivary Basic Proline-Rich Protein Family by Top-Down Mass SpectrometryTop-down proteomic profiling of human saliva in multiple sclerosis patientsEnrichments of post-translational modifications in proteomic studiesMapping of Transglutaminase-2 Sites of Human Salivary Small Basic Proline-Rich Proteins by HPLC-High-Resolution ESI-MS/MSQuantitative Analysis of the Seminal Plasma Proteome in Secondary HypogonadismProteomic evaluation of GCF in the development of pregnancy related periodontal disease: a pilot clinical studyRestoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndromeProtein Oxidative Damage in UV-Related Skin Cancer and Dysplastic Lesions Contributes to Neoplastic Promotion and ProgressionRP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody DeficienciesAltered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene
P50
Q28548603-2A933E15-5D18-4D29-82CE-A62A34B406A4Q30393581-187DAA6B-3079-466E-A82D-9D16496533E3Q33777050-B807DCB4-48A4-476D-8557-E1DDF1BA7A9EQ35147552-B25FC668-6418-42B7-99D1-7F294480D7B6Q37316072-4B225A16-CF40-4631-A4D1-904B3C5109B9Q37623033-2FC5F149-676E-4662-8F8F-51CC1DFE93EFQ37693078-4D1F23F8-60E1-4AAC-BD7A-3AAF13789404Q38256891-A697392E-6CB7-4FA2-9C0A-838A21DC0896Q38833713-24A1BA20-63E6-46B0-AA71-C9C32BC868A5Q39579961-598AF13D-9AC3-4F38-8DAC-3578FE7617C9Q40814501-1AE53DCD-055F-4EF8-9BFD-AF88F1058B70Q44190698-07F19D18-DA45-4E96-A860-419653A2D210Q46668908-B6818ED1-C3E0-4795-9A72-A7066C69869AQ47588904-814C3A1A-0E98-45E3-AADC-F47A19F0ED31Q47822145-D57A8C82-7DA7-4DAC-A596-D3C6B6487534Q48269466-B0D3D9D7-B0D8-40B6-9D81-9C7AD59F89F5Q51026114-6FDAE8EF-42D0-4E0B-BB04-7FC7D8A21F13Q51145946-CDB82C43-C57B-4E71-83D8-AE7EA8CB0475Q52590417-B87D0F7E-E3BA-4574-8A08-E75A7B4A276BQ52643153-ECD364E6-9106-4A70-9444-31B727515D9AQ52716043-13AC690A-FCF6-4FE5-AE9E-B6D79FA134B1Q54299541-CC4F568E-1796-4589-9BF7-8B4D1ABFA82DQ55279265-B283A2E0-E16F-449F-AE65-EB2343256BDDQ57471015-83F8FF82-8D9C-49F0-9158-B834DF214D67Q57752501-EC02FB63-9F58-4D2D-9E4B-C7D9D0DD1FB1Q58098877-0A3DCF46-98E2-4007-B0B0-13C6E456E4B0Q61895581-79BC9545-7494-491C-99D1-FCAE79CAFCA6Q65000412-416791F3-053B-4C82-AB33-992EC8D534EFQ90381356-5881EB60-6BC1-423F-8DDB-B0E03D7E71ADQ90476486-A56B99B2-C764-4047-8098-BD7981F7F930Q90666493-FAE8A0D3-8F3F-46D3-A298-338BC51A2C7FQ90818037-33041D60-3D4F-4120-A0BB-A037FA0D3579Q90832161-EA4A8644-39EF-4581-8A45-5BB962A68F43Q90871543-1C94817C-3818-405F-A676-FBFD17625AC9Q91807734-4A159F31-96ED-4D2E-869F-75A3175B46EBQ91821386-EAD28889-BE5D-4C07-A142-4C0218B5569EQ92399660-615D3025-E39A-4B8C-A93D-AEAACC4E41BDQ92446071-5F9E7F82-E5BF-4FB9-B9C0-E5340D91767DQ92508160-8184295B-5E1D-44A6-BC52-868E5A3DFBBBQ92529155-39128702-10AE-48A6-809C-D6E7DE644B2F
P50
description
researcher
@en
name
Massimo Castagnola
@en
type
label
Massimo Castagnola
@en
prefLabel
Massimo Castagnola
@en
P31
P496
0000-0002-0959-7259